The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for May 2019 (PDF).
This issue only contains one item relevant to primary care and that is a request to help to reverse the decline in reporting of suspected adverse drug reactions (ADRs). 2018 saw a fall in the number of reported suspected (ADRs) to the Yellow Card Scheme and this was consistent across several reporter groups including GP, hospital pharmacists, community pharmacists, hospital doctors and nurses. Readers are reminded of the ways Yellow Cards can be submitted and are reminded that duplicate reports can be detected. So, to avoid under-reporting, send a Yellow Card, even if you think someone else has done it.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« SMC Update - May 2019||NICE Guidance - May 2019 »|